sivifene inn usan developmental code name smallmolecule antineoplastic agent immunomodulator development tigris pharmaceuticals kirax corporation topical treatment cutaneous cancer specifically investigated treat highgrade squamous intraepithelial lesions hsil associated human papillomavirus hpv infection invasive carcinomas anogenital area cervical vaginal anal drug reached phase ii clinical trials prior initially due structural similarity tamoxifen sivifene thought selective estrogen receptor modulator serm subsequent research revealed bind estrogen receptor er possess antiestrogenic actual mechanism action sivifene unknown thought produce immunomodulating effects via upregulation tlymphocyte cell surface httpsenwikipediaorgwikisivifene